Trials / Completed
CompletedNCT02725086
Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open-label, Two-way Crossover, Open-label Clinical Trial to Compare Pharmacokinetic/Pharmacodynamic Properties and Safety after Subcutaneous Administration of Leucostim® and Neupogen® in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Leucostim® | |
| DRUG | Neupogen® |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-05-01
- First posted
- 2016-03-31
- Last updated
- 2016-11-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02725086. Inclusion in this directory is not an endorsement.